The Zebrafish (Danio rerio) In Vivo Model for Preclinical Toxicity Testing

Add bookmark

Zebrafish: The alternative vertebrate animal model

The zebrafish is emerging as a complement to existing in vitro technologies and established preclinical in vivo models that can be scaled for high throughput. Technological innovation has helped the zebrafish embryo gain ground as a disease model and an assay system for drug screening.  

Have Your Say
Rate this feature and give us your feedback in the comments section below

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended